If you made any changes in Pure these will be visible here soon.

Personal profile

Fields of Science

  • 3111 Biomedicine

International and National Collaboration Publications and projects within past five years.


Discovery and development of safe-in-man broad-spectrum antiviral agents

Andersen, P. I., Ianevski, A., Lysvand, H., Oksenych, V., Bjørås, M., Telling, K., Lutsar, I., Dampis, U., Irie, Y., Tenson, T., Kantele, A. & Kainov, D., Apr 2020, In : International Journal of Infectious Diseases. 93, p. 268-276 9 p.

Research output: Contribution to journalReview ArticleScientific

Open Access

Integrated drug profiling and CRISPR screening identify essential pathways for CAR T-cell cytotoxicity

Dufva, O., Koski, J., Maliniemi, P., Ianevski, A., Klievink, J., Leitner, J., Pölönen, P., Hohtari, H., Saeed, K., Hannunen, T., Ellonen, P., Steinberger, P., Kankainen, M., Aittokallio, T., Keränen, M. A. I., Korhonen, M. & Mustjoki, S., 27 Feb 2020, In : Blood. 135, 9, p. 597-609 13 p.

Research output: Contribution to journalArticleScientificpeer-review

Interactive visual analysis of drug-target interaction networks using Drug Target Profiler, with applications to precision medicine and drug repurposing

Tanoli, Z., Alam, Z., Ianevski, A., Wennerberg, K., Vähä-Koskela, M. & Aittokallio, T., Jan 2020, In : Briefings in Bioinformatics. 21, 1, p. 211-220 10 p.

Research output: Contribution to journalReview ArticleScientificpeer-review

Open Access

SynToxProfiler: An interactive analysis of drug combination synergy, toxicity and efficacy

Ianevski, A., Timonen, S., Kononov, A., Aittokallio, T. & Giri, A. K., 3 Feb 2020, In : PLoS Computational Biology. 16, 2, 13 p., 1007604.

Research output: Contribution to journalArticleScientificpeer-review

Open Access

Genome-wide off-targets of drugs: risks and opportunities

Giri, A. K., Ianevski, A. & Aittokallio, T., Dec 2019, In : Cell Biology and Toxicology. 35, 6, p. 485-487 3 p.

Research output: Contribution to journalEditorialScientific